Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Thatcher Ross Heumann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2606-3379; OpenAlex author ID A5072177879. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. Co-author DOI 10.1038/s41467-026-68324-4↗
  2. Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial Co-author DOI 10.1038/s41467-026-71968-x↗
  3. A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with r… Co-author DOI 10.1038/s41467-023-39196-9↗
  4. Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. Co-author DOI 10.1016/j.ccell.2022.10.001↗
  5. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Co-author DOI 10.1186/s13148-022-01367-8↗
  6. Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance. Co-author DOI 10.1007/s10555-021-09981-3↗
  7. Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance. Co-author DOI 10.1007/s10555-021-09999-7↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nilofer Saba Azad · 5 shared papers, 2021–2026 · strength 1.07
  2. Robert A. Anders · 4 shared papers, 2022–2026 · strength 0.61
  3. Hao Wang · 4 shared papers, 2022–2026 · strength 0.61
  4. Elizabeth M. Jaffee · 4 shared papers, 2022–2026 · strength 0.61
  5. Daniel A. Laheru · 4 shared papers, 2022–2026 · strength 0.61
  6. Marina Baretti · 3 shared papers, 2022–2026 · strength 0.51
  7. Elana Judith Fertig · 3 shared papers, 2022–2026 · strength 0.48
  8. Janelle Marie Montagne · 3 shared papers, 2022–2026 · strength 0.48
  9. Jae Woo Lee · 2 shared papers, 2026 · strength 0.38
  10. Saurav Daniel Haldar · 2 shared papers, 2026 · strength 0.38
  11. Luciane Tsukamoto Kagohara · 2 shared papers, 2026 · strength 0.38
  12. Mark M. Yarchoan · 2 shared papers, 2026 · strength 0.38
  13. Neeha Zaidi · 2 shared papers, 2026 · strength 0.38
  14. Won Jin Ho · 2 shared papers, 2026 · strength 0.38
  15. Katherine M. Bever · 2 shared papers, 2026 · strength 0.38
  16. Amanda L. Huff · 2 shared papers, 2026 · strength 0.38
  17. Jin Peng He · 2 shared papers, 2022–2023 · strength 0.23
  18. Keyu Li · 2 shared papers, 2022–2023 · strength 0.23
  19. Christopher L. Wolfgang · 2 shared papers, 2022–2023 · strength 0.23
  20. Tengyi Zhang · 2 shared papers, 2022–2023 · strength 0.23
  21. Lei Zheng · 2 shared papers, 2022–2023 · strength 0.23
  22. Amol Kumar Narang · 2 shared papers, 2022–2023 · strength 0.23
  23. Peter James O'Dwyer · 1 shared paper, 2022 · strength 0.13
  24. Dulabh Kaur Monga · 1 shared paper, 2022 · strength 0.13
  25. Nita Ahuja · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.